<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="363955">
  <stage>Registered</stage>
  <submitdate>31/03/2013</submitdate>
  <approvaldate>8/04/2013</approvaldate>
  <actrnumber>ACTRN12613000371796</actrnumber>
  <trial_identification>
    <studytitle>Trans fatty acid analysis in vegans </studytitle>
    <scientifictitle>A cross sectional study assessing plasma trans fatty acid levels in New Zealand vegans</scientifictitle>
    <utrn>U1111-1141-2843</utrn>
    <trialacronym />
    <secondaryid>nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Plasma fats in healthy vegans</healthcondition>
    <conditioncode>
      <conditioncode1>Diet and Nutrition</conditioncode1>
      <conditioncode2>Other diet and nutrition disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>1 sample of  plasma for fatty acid analysis at one time point</interventions>
    <comparator>participants in New Zealand Dairy from February 2011 to September 2011 - under review
studyACTRN12612000574842 	</comparator>
    <control>Historical</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Plasma fatty acid levels</outcome>
      <timepoint>baseline</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>corelations between plasma TFA levels.</outcome>
      <timepoint>baseline</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>1.	Aged over 18 years of age
2.	Able to give informed consent
3.	Are vegan
</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>100</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>1.	Ingestion of any animal product in the last 12 weeks
2.	On medications
</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods>Sample Size
Based on the interventional study at Auckland city hospital, a total of 20 patients will enter this study. It is expected that no ruminant TFA will be detected in the sample. 

Statistical analysis
Absolute levels of plasma phospholipids will be reported. Pearsons correlation coefficient will be used to assess the relationship between fatty acids. 
</statisticalmethods>
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs>Screening</purposeobs>
    <duration>Cross-sectional</duration>
    <selection>Defined population</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>6/05/2013</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>20</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>University of Auckland</primarysponsorname>
    <primarysponsoraddress>22 Princess Street, auckland,1030</primarysponsoraddress>
    <primarysponsorcountry>New Zealand</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>University of Auckland</fundingname>
      <fundingaddress>22 Princess Street, auckland, 1030</fundingaddress>
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>Hospital</othercollaboratortype>
      <othercollaboratorname>Auckland City Hospital
</othercollaboratorname>
      <othercollaboratoraddress>Park Rd, Grafton Auckland,1030</othercollaboratoraddress>
      <othercollaboratorcountry>New Zealand</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Trans fats are found in dairy and in processed foods. The type of trans fats found in each food source is thought to be unique. We have recently completed a study in 180 healthy people who were asked to change dairy intake. Despite evidence that dairy intake was significantly changed; the trans fats from dairy did not. We then tested 7 brands of milk and found these Trans fats in milk samples. 
The question remains, could these trans fats come from non-animal sources, or do humans have the capability of changing unsaturated fats into these trans fats (pretty unlikely). Testing trans fatty acid levels in vegans seems the best way to answer this question.
20 male or non-pregnant female age &gt;18 years of age who are vegan will be asked to have 1 blood test. We will do a mass spectrometry test to look at all fatty acids. All trans fats will be measured and if present, we will see if they correlate with each other.

</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Not yet submitted</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Northern A Health and Disability Ethics Committee</ethicname>
      <ethicaddress>Novotel Ellerslie
72-112 Greenlane Rd East,
Auckland
1051
</ethicaddress>
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate>3/04/2013</ethicsubmitdate>
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>jocelyne benatar</name>
      <address>Cardiovascular Research Unit
Cardiology Level 3 
Auckland City Hospital
Park Rd
Auckland
1030</address>
      <phone>+6421893886</phone>
      <fax />
      <email>jbenatar@adhb.govt.nz</email>
      <country>New Zealand</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>jocelyne benatar</name>
      <address>Cardiovascular Research Unit
Cardiology Level 3 
Auckland City Hospital
Park Rd
Auckland
1030</address>
      <phone>+6421893886</phone>
      <fax />
      <email>jbenatar@adhb.govt.nz</email>
      <country>New Zealand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>jocelyne benatar</name>
      <address>Cardiovascular Research Unit
Cardiology Level 3 
Auckland City Hospital
Park Rd
Auckland
1030</address>
      <phone>+6421893886</phone>
      <fax />
      <email>jbenatar@adhb.govt.nz</email>
      <country>New Zealand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>jocelyne benatar</name>
      <address>Cardiovascular Research Unit
Cardiology Level 3 
Auckland City Hospial
Park Rd
Auckland</address>
      <phone>+6421893886</phone>
      <fax />
      <email>jbenatar@adhb.govt.nz</email>
      <country>New Zealand</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>